This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit April 29, 2015

Not an AzPA member?

Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings.

Stay connected with AzPA!

 Like us on Facebook

 Follow us on Twitter



Nicotine Dependence Treatment CE Program — June 4-5
You’re invited to the University of Arizona Healthcare Partnership two-day program. Thursday, June 4 attend the Treatment Specialist for Nicotine Dependence Certification program to learn methods and techniques that support improved lifestyle choices. Certification candidates will examine elements of an evidence based intensive intervention, learn behavior change theories, practice Motivational Interviewing, explore the strength of validated assessment instruments and reflect on the endgame for nicotine addiction. Friday, June 5 attend the INSTRUCTOR Treatment Specialist for Nicotine Dependence Certification program. This program certifies candidates to teach the Nicotine Dependence Treatment Specialist practicum and to evaluate participant performance. For more information, click here.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

APF Fun Run 5K to Support Pharmacy Education
AzPA is hosting its 2nd Fun Run of 2015. Join your colleagues and friends for a 5K run — or walk — outside the beautiful Westin La Paloma Resort Sunday morning June 28. Proceeds benefit the Arizona Pharmacy Foundation — our 501 (c) 3 nonprofit that provides funds, materials and resources to the pharmacy profession and the public in order to further pharmacy patient-centered care.

Why participate?
Because it's fun. This is a great time to socialize while enjoying the beautiful scenery surrounding a seminar resort. Check off your daily workout and meet new people. Participants will receive either an APF T-shirt or water bottle (depending on event). Need a better reason? You can cross the finish line knowing you helped support a great cause — the advancement of pharmacy research and education.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Deadline Extended: 1st Annual AZ Residency Conference June 25
You still have time! Registration has been extended till June 1. The Arizona Pharmacy Association Residency Conference will provide a platform for residents and fellows to present their research. This conference also offers residents and preceptors a forum to network with colleagues. Conference attendees will have opportunities to receive teaching and training advice. Earn up to 6 CPEs! Join us at the Westin La Paloma in Tucson. Pharmacy Residents pay only $175 for the full day conference — hotel room included.

Register now!!

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Miss an issue of the AzPA Pharmacy Flash? Click here to visit the AzPA Pharmacy Flash archive page.


Date Event
June 25 Residency Conference
June 25 Psychiatric Certificate Program
June 25 APhA Pharmacist & Patient-Centered Diabetes Care Certificate Program
June 25 Immunization Certificate Program
June 25 NEW APhA Pharmacy-Based Cardiovascular Disease Risk Management
June 26-28 AzPA Annual Convention
June 28 Arizona Pharmacy Foundation Fun Run
Sept. 25 Anticoagulation Certificate Program
Sept. 25 Medication Therapy Management Certificate Program
Sept. 26 Fall Conference

Click here for a full event list.


How often are opioids for chronic pain truly misused?
By Dorothy L. Tengler
More than 1.5 billion people worldwide suffer from chronic pain, and treating it can be challenging for physicians. Doctors often resort to the use of chronic opioid therapy, which has increased substantially in recent years. A group of researchers recently reviewed 38 published studies of opioid analgesic drugs prescribed for chronic pain. The researchers noted that 35 of the 38 studies were conducted in the United States, a curious finding that perhaps suggests that this issue is of both high interest and is perhaps a problem that is somehow uniquely relevant to the U.S.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

How pharmacists can better assist deaf patients
Pharmacy Times
Pharmacists don't have to learn American Sign Language to effectively communicate with deaf and hard-of-hearing patients, but they do need to improve their knowledge, attitudes and comfort levels to ensure safe medication use in this underserved population.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

FDA to require new information for prescribing medications during pregnancy
Chicago Tribune
When Laura Wylie became pregnant for the second time, she confronted a vexing dilemma: Stay on the antidepressants that could have adverse effects on her developing baby or risk descending into a deep, black hole that left her feeling numb.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

FDA grants new indication for Cyramza for metastatic colorectal cancer
Pharmacy Practice News
Ramucirumab received a new indication for the treatment of patients with metastatic colorectal cancer. Specifically, ramucirumab was approved for use in combination with FOLFIRI for the treatment of mCRC patients whose disease has progressed during or shortly after first-line therapy with regimens containing bevacizumab, oxaliplatin and fluoropyrimidine.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Missed last week's issue? See which articles your colleagues read most.

    Maple syrup helps antibiotics defeat bacteria (Medical News Today)
Prior authorizations: Pharmacy's own little horror show (By Jason Poquette)
Epilepsy drug could protect eyesight of MS patients (Medical News Today)
Popular painkiller may subdue positive feelings (Pharmacy Times)
Workers seeking productivity in a pill are abusing ADHD drugs (The New York Times)

Don't be left behind. Click here to see what else you missed.

Pharmacists: Aren't you really providers already?
The National Law Review
The first part of this article discussed pharmacist provider status and argument both for and against it. Today's post now turns to regulatory hurdles, developments towards provider status and the acknowledgment of changing roles in the pharmacist workforce.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Too much supplementation may raise cancer risk
Pharmacy Times
Taking more nutritional supplements than needed may increase a patient’s risk of cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
Looking for similar articles? Search here, keyword CANCER.

No significant differences: Prednisolone or pentoxifylline for alcoholic hepatitis
A recent study compared prednisolone and pentoxifylline for the treatment of severe alcoholic hepatitis. The short-term mortality rate among patients with severe disease is greater than 30 percent. In all, about 1,100 patients with a diagnosis of alcoholic hepatitis and severe disease were randomly assigned to one of four groups: a group that received a pentoxifylline-matched placebo and a prednisolone-matched placebo, a group that received prednisolone and a pentoxifylline-matched placebo, a group that received pentoxifylline and a prednisolone-matched placebo, or a group that received both prednisolone and pentoxifylline.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Cost of multiple sclerosis medication continues to skyrocket
Tech Times
The prices of multiple sclerosis drugs continue to rise despite being available on the market for the past 10 to 15 years, a new study says.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

WHO releases new guidelines for prevention of NTDs
WHO has issued new guidelines for folate concentrations for women of reproductive age. Each year, about 300,000 babies worldwide are born with neural tube defects, but adequate daily consumption of folic acid before and during early pregnancy has been shown to significantly reduce the risk for NTDs.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Assistant Executive Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
April 22, 2015
April 15, 2015
April 8, 2015
April 1, 2015

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063